ロード中...

Anti-leukemic effects of the V-ATPase inhibitor Archazolid A

Prognosis for patients suffering from T-ALL is still very poor and new strategies for T-ALL treatment are urgently needed. Our study shows potent anti-leukemic effects of the myxobacterial V-ATPase inhibitor Archazolid A. Archazolid A reduced growth and potently induced death of leukemic cell lines...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Zhang, Siwei, Schneider, Lina S., Vick, Binje, Grunert, Michaela, Jeremias, Irmela, Menche, Dirk, Müller, Rolf, Vollmar, Angelika M., Liebl, Johanna
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4791247/
https://ncbi.nlm.nih.gov/pubmed/26496038
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!